Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Sunday, September 13, 2026

Back to today

Lululemon: The 15-Minute Thesis

Lululemon’s North American sales, margins and legging demand are falling as Alo and Vuori gain share, leaving its brand moat and depressed valuation in question.

LULU $11B
Hated Moats 2 clicks

From X

@marginofdanger 1 click

marginofdanger on X

Ackman's closed end fund $PSUS will begin trading on Wednesday. For every 5 shares of PSUS, IPO investors (only) will get 1 share of $PS (the GP). It sounds like the PSUS offering will be 100mm shares at $50/share or $5 bn. Ackman thought this was going to be a $10 bn offering and he previously was targeting $25 bn or some ridiculous amount. The PSUS IPO investors will end up owning 20mm shares or 5% of PS (based on 400mm pf s/o). I expect that PSUS, like many closed end funds, will settle at a 5-10% discount to NAV, implying a trading price of $45-47.50/share. PS will begin trading as well (via a direct listing) and I anticipate a valuation of $5-10bn, implying that the PSUS IPO investors will get a "bonus" of $250-500mm on the $5 bn IPO or 5-10%. Therefore their loss on the PSUS shares should be mostly offset by the free shares in PS. Given this is a direct listing, I expect WILD price movements in PS stock and would stay far away from that one. I used $10 bn as the high end valuation for PS because that is where investors invested back a year or so ago (predicated upon significant growth in AUM), but I tend to believe that was a high watermark and not realistic given that Ackman can't seem to raise $. In terms of $PSUS, I don't see a compelling reason to own this at 90-95% of NAV. If you put a 15x on the 2% fee, that alone is a 30% drag. Also, Ackman has high volatility and there is no prospect to ever get repaid (and no incentive for Ackman to do so). Like $PSH.LN I would personally only step into $PSUS at a 25-30%+ discount to NAV and probably not in any real size.
@MultiplesCap

Multiples Capital on X

I recently sat down with @StockJabber at @IdeaBrunchEmail to discuss the strategy behind Multiples Capital's outperformance in 2025. The full interview is behind a paywall, but here are 4 core themes we discussed: 1/ The Multi-Asset Edge While many leaned on the "Magnificent 7," we found alpha in global de-dollarization and the massive electricity demands of AI data centers. This approach delivered a 3.15 Sharpe Ratio—with roughly half the turbulence of the S&P 500. 2/ Garrett Motion ($GTX) Update Since my last feature, $GTX has surged ~170%. We discussed the "perfect storm" of index inclusion and aggressive capital allocation that drove this run, and why the "EV-only" fear proved to be premature. 3/ AI Disruption vs. Mispricing The market is correctly identifying "AI Losers" in SaaS, but it’s applying that same anxiety with broad stroke. We broke down why Expedia ($EXPE) is a prime example of this mispricing, trading at a 12%+ FCF yield despite its essential role in the global travel ecosystem and it's growing B2B setment. 4/ My Favorite "Tokenization" Play We closed with a deep dive into the digitalization of finance. I shared my top idea for playing the tokenization trend, a company currently acting as the "digital infrastructure provider" for institutions and growing it's subscription and service revenues. Read the full deep dive here: https://t.co/kuRyJtSPMh Note: As this is premium content, I cannot share the PDF on a open platform. However, if you’d like to join my quarterly investor letter distribution list to see how we are positioning for the "Broadening Trade" in 2026, please send a DM.

Investor Letters

All letters

TSOH Weekly Roundup (09/11/2026)

TSOH weekly roundup covers Meta’s child-safety settlement, Markel’s leadership transition, Peloton’s gym strategy and an upcoming Alarm.com…

MKL $22B
TSOH Investment Research 2 clicks

Lululemon: Deep Dive Analysis

Lululemon’s Q2 revenue fell 4% and Americas comparable sales 12%, as markdowns, tariffs and activewear rivals pressure its premium apparel…

LULU $11B
Hated Moats 6 clicks
UHS · long

Universal Health Svcs INC

Universal Health Services is a profitable hospital operator whose $146 share price over-discounts an earnings-collapse scenario.

UHS $10B
Value Investors Club 5 clicks

Publications we follow

Every publication on this site, hand-picked.

108 publications

Newsletters 91

YouTube 4

Blogs 12

Seeking Alpha 29 of 160

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

69 accounts
Nominate an account

Investor letters we follow

78 firms

Sectors

Ordered by how often our editor reaches for them.